Rituximab as Rescue or Add-On Therapy for Relapsing or Refractory Lupus Nephritis: A Systematic Review and Meta-Analysis. (PubMed, Clin Transl Sci) - Sep 30, 2026 - "In conclusion, RTX-based rescue or add-on therapy was associated with moderate renal response rates and reductions in proteinuria and serum creatinine in this difficult-to-treat population. Further prospective comparative studies are needed to define its role."
Clinical • Journal • Retrospective data • Review • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease
|
|
Fuling Wang; Guichun Tang; Meng Li; Qian Wang; Shuang Liang; Weizhu Deng; Xiaolong Wang; Xiaowei Sun; Zheyi Dong
|